Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine
Published
Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
Full Article